PUBLIC COMPANY
saveTranslational Sciences Inc
updated 3mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Chutes & Ladders—Longtime Takeda R&D chief to depart next JuneTakeda President of Research and Development Andy Plump, M.D., Ph.D., is leaving the company in June after twelve years in the position.fiercebiotech · 7d ago
- Biotech leaders call for streamlining of INDs as FDA’s Trialblazer rolls outThe FDA’s new investigational new drug pilot program—one part of HHS’s broader clinical trial modernization initiatives—has lofty goals to expedite first-in-human trials of novel drugs, but experts…biospace · 1mo ago
- Opinion: The VA could help America win the biotechnology race with China“Together, HHS, the VA, and the DOD form a strong American innovation ecosystem — one that China and other competitors cannot easily replicate,” writes former VA Secretary David Shulkin.stat · 1mo ago
- De-Risking a Rare Disease Launch Starts with PrecisionWhy traditional models fall short in rare disease commercialization—and what works instead.fiercebiotech · 2mo ago
- NIH-funded research lags in reporting sex differences, new study findsFewer than half of papers published by NIH-funded researchers analyze or report their data by sex, a new study found.stat · 4mo ago
comments(0)
5-min edit window · permanent after that